San Diego, United States
Cytonus Therapeutics is at the forefront of a new wave in the Biotechnology and Health Care industries, challenging outdated pharmacodynamics with its innovative Cargocyte platform. Founded in 2018 and based in the United States, the company seeks to revolutionize drug-discovery and delivery. The Cargocyte platform promises precision drug delivery and in-vivo drug production, aiming for heightened efficacy without sacrificing patient safety.
The startup recently bolstered its growth potential with a $11.70M Series A investment led by a consortium of investors including Creative Ventures, Partners Investment, Proxima Ventures, Gemseki Inc., Wilson Sonsini Goodrich & Rosati, KreaMedica, and John Ballantyne on 03 November 2023. This influx of capital provides Cytonus Therapeutics the resources to further develop its paradigm-shifting technologies, reinforcing its mission encapsulated in its slogan: "Launching a Therapeutic Revolution to Transform Your Health©️".
